What is the recommended dosing for Bromfed (brompheniramine and pseudoephedrine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bromfed Dosing

Bromfed (brompheniramine/pseudoephedrine) is dosed as 5 mL (containing brompheniramine 2 mg and pseudoephedrine 30 mg) every 4-6 hours for adults and children over 12 years, with pediatric dosing requiring weight-based calculation and caution due to limited safety data in young children. 1

Standard Adult Dosing

  • Each 5 mL (1 teaspoonful) contains brompheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg 1
  • Administer every 4-6 hours as needed for nasal congestion and allergic symptoms 1, 2
  • The pseudoephedrine component (60 mg per 10 mL dose) demonstrates significant decongestant efficacy with objective reduction in nasal airway resistance within 0-4 hours after administration 2

Pediatric Considerations

  • Brompheniramine 4 mg produces prompt onset (within 0.5 hours) and sustained H1-blockade lasting up to 30 hours in children, with peak plasma concentrations at approximately 3 hours 3
  • The terminal elimination half-life in children is 12.4 hours, suggesting once or twice daily dosing may be more appropriate than the traditional every 4-6 hour regimen 3
  • Exercise extreme caution in infants and young children—fatal intoxications have been reported with cold medication combinations containing these ingredients 4
  • Dosing in children should be weight-based and significantly reduced from adult doses, though specific pediatric dosing for this combination is not well-established in the provided evidence 3, 4

Pharmacokinetic Profile

  • Brompheniramine achieves maximum wheal suppression at 12 hours (52% inhibition) and maximum flare suppression at 6 hours (72% inhibition) in children 3
  • Pseudoephedrine demonstrates consistent bioavailability with mean biological half-life of 8 hours 5
  • The combination maintains therapeutic levels when dosed every 6-12 hours depending on formulation 5

Critical Safety Warnings

  • Monitor heart rate—pseudoephedrine increases heart rate by 2-4 beats per minute on average 2
  • Avoid use in infants due to documented fatal overdoses with this drug combination 4
  • The narrow therapeutic index in pediatric patients requires precise dosing and parental education on proper measurement 4
  • Do not exceed recommended dosing intervals or amounts, as toxic concentrations can accumulate rapidly in small children 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.